(Q44290658)

1 December 2017

BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration (English)

1 reference

1 December 2017

1 reference

1 reference

6

1 reference

1 December 2017

Lynda J Campbell

1

1 reference

1 December 2017

Crisoula Patsouris

2

1 reference

1 December 2017

Kathleen C Rayeroux

3

1 reference

1 December 2017

Kathy Somana

4

1 reference

1 December 2017

E Henry Januszewicz

5

1 reference

1 December 2017

1 November 2002

1 reference

Cancer Genetics and Cytogenetics

1 December 2017

1 reference

1 December 2017

139

1 reference

1 December 2017

30-33

1 reference

1 December 2017

1

1 reference

Chronic granulocytic leukemia: correlation of blastic transformation type with karyotypic evolution

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900615-5

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900615-5

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900615-5

7 January 2021

Amplification of the human dihydrofolate reductase gene via double minutes is initiated by chromosome breaks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900615-5

7 January 2021

Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900615-5

7 January 2021

Cytogenetics of the chronic myeloid leukemia-derived cell line K562: karyotype clarification by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and locus-specific fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900615-5

7 January 2021

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900615-5

7 January 2021

10.1016/S0165-4608(02)00615-5

Identifiers

DOI

1 reference

1 December 2017

1 reference